CECCHETTI, Violetta
 Distribuzione geografica
Continente #
NA - Nord America 5.246
EU - Europa 4.256
AS - Asia 2.006
AF - Africa 17
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 7
Totale 11.548
Nazione #
US - Stati Uniti d'America 5.228
UA - Ucraina 882
IE - Irlanda 867
IT - Italia 790
SG - Singapore 639
SE - Svezia 638
VN - Vietnam 491
HK - Hong Kong 417
CN - Cina 296
DE - Germania 247
FI - Finlandia 197
RU - Federazione Russa 186
BE - Belgio 105
GB - Regno Unito 101
FR - Francia 60
TR - Turchia 45
RO - Romania 44
JP - Giappone 38
CH - Svizzera 34
KR - Corea 27
NL - Olanda 26
PL - Polonia 24
UZ - Uzbekistan 20
CZ - Repubblica Ceca 17
AT - Austria 16
CI - Costa d'Avorio 11
CA - Canada 10
LB - Libano 9
AU - Australia 8
MX - Messico 8
EU - Europa 7
GR - Grecia 7
IN - India 7
IR - Iran 7
EG - Egitto 5
DK - Danimarca 4
BG - Bulgaria 3
BR - Brasile 3
CL - Cile 3
MY - Malesia 3
ES - Italia 2
HU - Ungheria 2
LT - Lituania 2
PK - Pakistan 2
AZ - Azerbaigian 1
ID - Indonesia 1
IQ - Iraq 1
KZ - Kazakistan 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 11.548
Città #
Chandler 1.091
Dublin 867
Singapore 539
Dong Ket 487
Jacksonville 480
San Mateo 460
Hong Kong 404
Boardman 307
Perugia 284
Santa Clara 231
Medford 205
Princeton 203
Ann Arbor 167
Wilmington 159
Altamura 146
Andover 128
Lawrence 123
Brussels 105
Beijing 102
Fremont 75
Des Moines 65
Saint Petersburg 57
Ashburn 48
West Jordan 48
Izmir 43
Redmond 43
Norwalk 39
Dearborn 36
Woodbridge 35
Tokyo 33
Los Angeles 29
Falls Church 27
Bucharest 25
Spoleto 25
Helsinki 24
Seoul 24
San Giustino 23
San Paolo di Civitate 22
Redwood City 21
Dallas 19
Moscow 18
New York 18
Nanjing 17
San Diego 17
Den Haag 16
Rome 16
Shanghai 16
Auburn Hills 14
Hanover 13
Philadelphia 12
Abidjan 11
Munich 11
Timisoara 11
Houston 9
Olomouc 8
Guadalupe 7
Lausanne 7
Melbourne 7
Ottawa 7
Radomsko 7
West Lafayette 7
Bologna 6
Frankfurt Am Main 6
Kunming 6
Mcallen 6
Napoli 6
San Jose 6
Seattle 6
Brno 5
Milan 5
Romola 5
Terni 5
Zhengzhou 5
Anguillara Sabazia 4
Arak 4
Cambridge 4
Fairfield 4
Hanoi 4
London 4
Nantong 4
Simi Valley 4
Urbino 4
Wuhan 4
Xian 4
Alameda 3
Cerro Maggiore 3
Chengdu 3
Chicago 3
Chongqing 3
Edinburgh 3
Ferrara 3
Florence 3
Guangzhou 3
Hangzhou 3
Lanciano 3
Mit Ghamr 3
Nichelino 3
Serra 3
Shaoyang 3
Siena 3
Totale 7.657
Nome #
1,4-Benzothiazine-2-carboxylic Acids 1-Oxide as Analogue of Antibacterial Quinolones 249
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 230
(1,4-Benzothiazinyloxy)alkylpiperazine Derivatives as Potential Antihypertensive Agents 227
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 196
6-Aminoquinolones, their Synthesis and their Use as Antibacterial Agents. 156
Derivati benzotiazinici come inibitori della pompa estrudente MDR NorA dello Staphylococcus aureus 119
Sintesi di nuovi inibitori della pompa di efflusso NorA dello S. aureus: dalle 3-fenil-1,4-benzotiazine alle 2-fenilchinossaline 118
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 118
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 107
Attivatori dei canali KATP a struttura 1,4-benzotiazinica. Modificazioni in N-4 106
4H-1,4-Benzothiopyran-4-one-3-carboxylic Acids and 3,4-Dihydro-2H-isothiazolo[5,4-b][1]benzothiopyran-3,4-diones as Quinolone Antibacterial Analogs 104
Attivatori dei canali K-ATP a struttura 1,4-benzotiazinica: modificazioni in C-2 e C-6 95
SINTESI DI NUOVI INIBITORI DELLA POMPA DI EFFLUSSO NorA DELLO S. aureus: DALLE 3-FENIL-1,4-BENZOTIAZINE ALLE 2-FENILCHINOLINE 94
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 94
6-Aminoquinolones: a New Class of Quinolone Antibacterials? 91
Chemometric Rationalization of the Structural and Physicochemical Basis for Selective Cyclooxygenase-2 Inhibition: Toward More Specific Ligands 89
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 89
Syhtesis and Biological Evaluation of 2-Phenylquinolones Targeted at Tat/TAR Recognition 87
Process for the Preparation of 9-Fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic Acid Hydrochloride 83
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 79
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 78
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 78
A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors 77
Cell-dependent Interference with viral transactivation by 6-aminoquinolone derivatives. 76
Studies on 6-Aminoquinolones: Synthesis and Antibacterial Evaluation of 6-Amino-8-ethyl- and 6-Amino-8-methoxyquinolones 75
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 75
Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development 75
Disegno e Sintesi di Nuovi Inibitori Allosterici della NS5B Polimerasi dell'HCV 74
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 74
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 74
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 74
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 73
Chemometric Rationalization of the Structural Features Affecting the Antibacterial Activity of Quinolones Against Staphylococcus aureus 72
The antibacterial activity of quinolones against E.coli: a chemometric study 72
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 72
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 72
6-Desfluoroquinolones as promising HIV transcription inhibitors 71
7-(Disubstituted thiazolyl)-3,5-dihydroxy-6-heptenoic/heptanoic acid derivatives as HMG-COa reductase inhibitors 71
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 71
Synthesis of 2-(Arylamino)ethanethiols via Lewis Acid catalyzed Aminolysis of 2,2-Dimethylthiirane as Precursors of the 1,4-Benzothiazine Nucleus 70
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 70
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 69
Chemometric Methodologies in a Quantitative Structure-Activity Relationship Study: the Antibacterial Activity of 6-Aminoquinolones 69
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 69
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 69
QSAR study and VolSurf characterization of anti-HIV quinolone library 68
Studies on Anti-HIV Quinolones: New Insights on the C-6 Position 68
6-Aminoquinolones as New Potential Anti-HIV Agents 67
Synthesis and Antibacterial Evaluation of [1,3]Benzothiazino[3,2-a]quinoline and [3,1]Benzothiazino[1,2-a]quinoline-6-carboxylic Acid Derivatives 66
8-Methyl-7-substituted-1,6-naphthyridine-3-carboxylic Acids as New 6-Desfluoroquinolone Antibacterials 66
Advantageous Use of Ionic Liquids for the Synthesis of Pharmaceutically Relevant Quinolones 66
Deciphering the molecular recognition mechanism of multidrug resistance staphylococcus aureus nora efflux pump using a supervised molecular dynamics approach 66
New Insights on KCa3.1 Channel Modulation 66
A New Derivative with Ultra-Potent Anti-HIV Activity 65
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 65
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 65
Structure-based insights into p38α MAPK: from crystal structures analysis to hit optimization 64
A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates 64
Chemometric rationalization of the structural features affecting the antibacterial activity of quinolones 64
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 64
Enantiomers of 8-(3-tert-Butylamino-2-hydroxypropoxy)-3,4-dihydro-3-oxo-2H-(1,4)benzothiazine: Racemic Resolution, Chiral Synthesis and Biological Activity. 64
In Vitro Activities of New Quinolones Against Helicobacter pylori 63
New Heterocyclic Ring Systems. XIII.7,11-Dithiaazasteroid Analogues 63
A new 6-aminoquinolone compound with anti-HCMV activity 63
S. aureus NorA efflux pump: the discovery of new potent inhibitors 63
Bicyclic octahydrocyclohepta[b]pyrrol-4(1H)one derivatives as novel selective anti-hepatitis C virus agents 63
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 63
Synthesis of Novel Inhibitors of the S. aureus Efflux pumps: from the 4-hydroxy-2-phenylquinolines to the 4-hydroxy-2-phenylquinazolines 62
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 62
Proceedings of the X National Biotechnology Congress. 61
One-Pot Synthesis of Rufloxacin 61
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 61
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 61
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein 60
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. 60
p38 alpha MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening 60
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 60
Quinolones as potential anti HIV-1 agents targeted at Tat/TAR recognition 59
6-Aminoquinolones: photostability, cellular distribution and phototoxicity. 59
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 59
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 59
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 58
Cinnamoyl compounds as small-molecules inhibitors of histone acetyltransferase enzymes 58
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 58
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 58
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 58
Nuovi 6-DFQ come inibitori della Transattivazione dell’HIV-1 57
Disegno e sintesi di agenti anti-HIV a duplice attività 57
N-Benzoyl-N-methylsulfonyl anthranilates: unexpected cyclization reaction to 4-alkoxy-2,1-benzothiazines 57
Pyrazolobenzothiazines as potent TNF-alpha production inhibitors. 57
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 57
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 56
Symbiotic approach to drug design: N-[(4-chloro-3-sulfamoylbenzamido)-ethyl]propanolamine derivatives as β-adrenergic blocking agents with diuretic activity 56
RE-EVOLUTION OF THE 2-PHENYL-4-HYDROXYQUINOLINES: OPTIMIZATION OF A POTENT NEW CLASS OF S. AUREUS NorA EFFLUX PUMP INHIBITORS 56
Structure modifications of 6-aminoquinolones with potent anti-HIV activity 55
Sali Quaternari di Aminoetil-p-aminobenzoati e Aminoetil-p-aminobenzamidi. Sintesi ed Attività Farmacologica 55
Chemometric Studies on the Bactericidal Activity of Quinolones via an Extended VolSurf Approach 55
A 6-Aminoquinolone Compound, WC5, with Potent and Selective Anti-Human Cytomegalovirus Activity. 54
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 53
A Comprehensive Structural Overview of p38 Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site Binders 53
Totale 7.689
Categoria #
all - tutte 49.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.498


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020748 0 0 0 0 132 48 177 19 158 121 16 77
2020/20212.280 17 151 65 162 539 152 209 14 233 68 147 523
2021/20222.004 58 337 42 129 145 17 48 570 88 58 241 271
2022/20233.237 227 527 49 304 282 338 3 164 1.156 24 119 44
2023/20241.396 83 192 68 32 24 39 292 34 171 93 169 199
2024/20251.160 51 287 122 298 402 0 0 0 0 0 0 0
Totale 12.088